missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Kallikrein 8/Neuropsin Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Enzyme Activity
Marke: R&D Systems™ 2025-SE-010
417.26 CHF gültig bis 2024-12-16
Benutzen Sie den Promotions-Code "21630" um Ihren Promotions-Preis zu erhalten.
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
The Recombinant Human Kallikrein 8/Neuropsin Protein is derived from NS0. The Recombinant Human Kallikrein 8/Neuropsin Protein has been validated for the following applications: Enzyme Activity.Spezifikation
| Supplied as a 0.2μm filtered solution in Tris and NaCl. | |
| Observed Molecular Wt.: 37-39 kDa, reducing conditions | |
| 10 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70° C as supplied. 3 months, -20 to -70° C under sterile conditions after opening. | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 11202 | |
| Kallikrein 8/Neuropsin | |
| Mouse myeloma cell line,NS0-derived human Kallikrein 8/Neuropsin protein Gln29-Gly260,with a C-terminal 10-His tag | |
| Pro form | |
| Recombinant |